CMXC
Price:
$0.425
Market Cap:
$126.33M
Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed ...[Read more]
Industry
Medical - Devices
IPO Date
2013-08-29
Stock Exchange
OTC
Ticker
CMXC
According to Cell MedX Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -42.50. This represents a change of 264.34% compared to the average of -11.67 of the last 4 quarters.
The mean historical PE Ratio of Cell MedX Corp. over the last ten years is -127.49. The current -42.50 PE Ratio has changed 3.23% with respect to the historical average. Over the past ten years (40 quarters), CMXC's PE Ratio was at its highest in in the May 2017 quarter at 102.66. The PE Ratio was at its lowest in in the May 2020 quarter at -668.41.
Average
-127.49
Median
-72.42
Minimum
-447.81
Maximum
-13.07
Discovering the peaks and valleys of Cell MedX Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 465.50%
Maximum Annual PE Ratio = -13.07
Minimum Annual Increase = -92.17%
Minimum Annual PE Ratio = -447.81
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -14.37 | 9.96% |
| 2024 | -13.07 | -76.37% |
| 2023 | -55.29 | -59.07% |
| 2022 | -135.07 | -51.87% |
| 2021 | -280.65 | -37.33% |
| 2020 | -447.81 | 465.50% |
| 2019 | -79.19 | 20.62% |
| 2018 | -65.65 | -49.31% |
| 2017 | -129.51 | 138.31% |
| 2016 | -54.34 | -92.17% |
The current PE Ratio of Cell MedX Corp. (CMXC) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-27.57
5-year avg
-99.69
10-year avg
-127.49
Cell MedX Corp.’s PE Ratio is less than Anteris Technologies Ltd (-2.70), less than Japan Medical Dynamic Marketing, Inc. (-18.61), less than China Medical & HealthCare Group Limited (58.48), less than Prescient Therapeutics Limited (0), less than Green Rain Energy Holdings Inc. (-24.32), less than Leafly Holdings, Inc. (-21.82), less than Creso Pharma Limited (-0.40), less than Respiri Limited (-5.28), less than Broncus Holding Corporation (-10.21), less than Carmat S.A. (-0.04),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.70 | $120.50M | |
| -18.61 | $94.12M | |
| 58.48 | $123.01M | |
| 0 | $117.53M | |
| -24.32 | $83.49K | |
| -21.82 | $114.90M | |
| -0.40 | $131.72M | |
| -5.28 | $91.52M | |
| -10.21 | $42.11M | |
| -0.04 | $85.19M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cell MedX Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cell MedX Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cell MedX Corp.'s PE Ratio?
How is the PE Ratio calculated for Cell MedX Corp. (CMXC)?
What is the highest PE Ratio for Cell MedX Corp. (CMXC)?
What is the 3-year average PE Ratio for Cell MedX Corp. (CMXC)?
What is the 5-year average PE Ratio for Cell MedX Corp. (CMXC)?
How does the current PE Ratio for Cell MedX Corp. (CMXC) compare to its historical average?